Parvo Vaccine

Verify with FDA CVM →

254 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
254
Total Reports
22
Deaths Reported
870.0%
Death Rate

Active Ingredients

Parvo Vaccine

Administration Routes

UnknownParenteralSubcutaneous

Species Affected

Dog 253
Unknown 1

Most Affected Breeds

Retriever - Labrador 24
Pit Bull 13
Retriever - Golden 13
Chihuahua 12
Boxer (German Boxer) 12
Shepherd Dog - German 12
Dachshund (unspecified) 8
Bulldog 8
Maltese 7
Spaniel - Cocker American 6

Most Reported Reactions

Vomiting 85
Emesis 78
Lethargy (see also Central nervous system depression in 'Neurological') 65
Diarrhoea 28
Seizure NOS 17
Not eating 16
Behavioural disorder NOS 16
Anaemia NOS 15
Other abnormal test result NOS 14
Shaking 14
Emesis (multiple) 14
Ataxia 11

Outcome Breakdown

Recovered/Normal
144 (56.9%)
Outcome Unknown
39 (15.4%)
Ongoing
29 (11.5%)
Recovered with Sequela
19 (7.5%)
Died
14 (5.5%)
Euthanized
8 (3.2%)

Data Summary

Metric Value
Total adverse event reports 254
Reports involving death 22
Case-fatality rate (reported events) 870.0%
Distinct species in reports 2
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Parvo Vaccine Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 254 adverse event reports referencing Parvo Vaccine, including 22 reports in which the animal died — a 870.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Parvo Vaccine. Reported administration routes include Unknown, Parenteral, Subcutaneous. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Parvo Vaccine reports are Dog (253 reports), Unknown (1 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (24), Pit Bull (13), Retriever - Golden (13) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Parvo Vaccine are Vomiting (85), Emesis (78), Lethargy (see also Central nervous system depression in 'Neurological') (65), Diarrhoea (28). Of the 253 reports with a coded outcome, Recovered/Normal is the leading category at 56.9%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Parvo Vaccine.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial